Share the post "MEDICO REMEDIES announces Q1 Report: Revenue Dropped by 2.14% YoY"
Highlights
- The presented financial data is Standalone to provide a comprehensive overview of the company performance.
- Sales over the Year and quarter: The company’s sales declined by -2.14 % over the year, decrease in net sales/revenue by -25.47 %.
- Income over the Year and quarter: There has been decline in other income over the past year which is -6.69 %, Marginal decrease of -49.83% in other income during this quarter.
- Profit over the Year and quarter: Significant improvement in profitability for MEDICO REMEDIES LIMITED. Notable increase of 19.62 % in net profit Year to Year, MEDICO REMEDIES LIMITED’s profitability dropped by -49.05 % Quarter to Quarter.
- EPS over the Year and quarter: EPS increased by 18.75 % Year to Year. EPS decreased by -48.65 % in previous quarter. Analysis needed for shareholder value.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 31.47 Cr | Rs. 41.323 Cr | Rs. 30.798 Cr | -25.47 % | -2.14 % |
| Expenses | Rs. 29.02 Cr | Rs. 36.67 Cr | Rs. 27.98 Cr | -23.7 % | -3.58 % |
| Operating Profit | Rs. 2.45 Cr | Rs. 4.65 Cr | Rs. 2.82 Cr | -39.35 % | + 15.1 % |
| OPM % | 7.79 % | 11.25 % | 9.16 % | -2.09 % | + 1.37 % |
| Other Income | Rs. 0.314 Cr | Rs. 0.584 Cr | Rs. 0.293 Cr | -49.83 % | -6.69 % |
| Interest | Rs. 0.17 Cr | Rs. 0.25 Cr | Rs. 0.18 Cr | -28 % | + 5.88 % |
| Depreciation | Rs. 0.71 Cr | Rs. 0.74 Cr | Rs. 0.75 Cr | + 1.35 % | + 5.63 % |
| Profit before tax | Rs. 1.88 Cr | Rs. 4.24 Cr | Rs. 2.18 Cr | -48.58 % | + 15.96 % |
| Tax % | 29.9 % | 27 % | 27.4 % | + 0.4 % | -2.5 % |
| Net Profit | Rs. 1.32 Cr | Rs. 3.1 Cr | Rs. 1.58 Cr | -49.03 % | + 19.7 % |
| EPS in Rs | Rs. 0.16 | Rs. 0.37 | Rs. 0.19 | -48.65 % | + 18.75 % |
Today, we’re looking at MEDICO REMEDIES LIMITED’s financial performance for the Q1(Jun 2024).Starting with the top line, the company reported a significant year-over-year sales decline of -2.14 %. However, it did see a marginal slip of -25.47 % from the previous quarter. Expenses decreased slightly by -23.7 % quarter-on-quarter, aligning with the annual decline of -3.58 %. Operating profit, while up 15.1 % compared to last year, faced a quarter-on-quarter dip of -39.35 %, signaling a short-term contraction in margins.
The Operating Profit Margin (OPM) % echoes this narrative, showing resilience on an annual basis with an increase of 1.37 %, but a shrinkage of -2.09 % sequentially. Other income fell by -49.83 % compared to the last quarter, despite an annual decline of -6.69 %. Interest expenses dropped significantly by -28 % from the previous quarter, yet the year-over-year increase remains at a moderate 5.88 %. Depreciation costs climbed by 1.35 % quarter-on-quarter, whereas on an annual scale, they saw an increase of 5.63 %. Profit before tax grew annually by 15.96 % but saw a reduction from the preceding quarter by -48.58 %.
Tax expenses as a percentage of profits decreased slightly by -2.5 % compared to last year, with a more notable quarter-on-quarter increase of 0.4 %. Net profit rose by 19.7 % year-on-year but witnessed a -49.03 % contraction from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual uptick of 18.75 % but a quarterly fall of -48.65 %. In summary, MEDICO REMEDIES LIMITED’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 31.47 Cr | Rs. 41.323 Cr | Rs. 30.798 Cr | -25.47 % | -2.14 % |
| Expenses | Rs. 29.02 Cr | Rs. 36.67 Cr | Rs. 27.98 Cr | -23.7 % | -3.58 % |
| Operating Profit | Rs. 2.45 Cr | Rs. 4.65 Cr | Rs. 2.82 Cr | -39.35 % | + 15.1 % |
| Net Profit | Rs. 1.32 Cr | Rs. 3.1 Cr | Rs. 1.58 Cr | -49.03 % | + 19.7 % |
| EPS in Rs | Rs. 0.16 | Rs. 0.37 | Rs. 0.19 | -48.65 % | + 18.75 % |
In reviewing MEDICO REMEDIES LIMITED’s 2024(Q1) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales experienced a decrease of -2.14 % year-on-year, although there was a slight dip of -25.47 % from the previous quarter. Expenses decreased by -3.58 % compared to the previous year, with a decrease of -23.7 % quarter-on-quarter. Operating Profit surged by 15.1 % annually, and saw a -39.35 % decrease from the last quarter.
Net Profit showed yearly increase of 19.7 %, and experienced a -49.03 % decrease from the previous quarter. Earnings Per Share (EPS) rose by 18.75 % annually, however dipped by -48.65 % compared to the last quarter. In essence, while MEDICO REMEDIES LIMITED exhibits strong annual growth indicators, short-term fluctuations suggest the need for agile strategies to navigate market dynamics effectively. That’s all for now in the financial sector.
[my_shortcode1]
![[fetch_key]](https://stocktradeupdates.com/wp-content/uploads/new_logos/ASMTEC.png)